Literature DB >> 4255439

Toxicity form rifampicin plus isoniazid and rifampicin plus ethambutol therapy.

A W Lees, G W Allan, J Smith, W F Tyrrell, R J Fallon.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1971        PMID： 4255439     DOI： 10.1016/0041-3879(71)90041-9

Source DB:  PubMed          Journal:  Tubercle        ISSN： 0041-3879


× No keyword cloud information.
  19 in total

1.  Eidotorial: Antituberculous drugs and the liver.

Authors: 
Journal:  Br Med J       Date:  1975-06-07

2.  Ethionamide+cycloserine+pas vs isoniazid+streptomycin+pas in initial antiburerculosis chemotherapy followed by the standard regimen. A controlled study with special reference to the microscopic enumeration of bacillia as a criterion of efficacy.

Authors: 
Journal:  Pneumonologie       Date:  1975

3.  Dynamics of Mycobacteriophage-Mycobacterial Host Interaction: Evidence for Secondary Mechanisms for Host Lethality.

Authors:  Sourabh Samaddar; Rajdeep Kaur Grewal; Saptarshi Sinha; Shrestha Ghosh; Soumen Roy; Sujoy K Das Gupta
Journal:  Appl Environ Microbiol       Date:  2015-10-16       Impact factor: 4.792

Review 4.  Tuberculosis--chemotherapy.

Authors:  K M Citron
Journal:  Br Med J       Date:  1972-02-12

5.  Adverse reactions to daily and intermittent rifampicin regimens for pulmonary tuberculosis in Hong Kong.

Authors:  M Aquinas; W G Allan; P A Horsfall; P K Jenkins; W Hung-Yan; D Girling; R Tall; W Fox
Journal:  Br Med J       Date:  1972-03-25

6.  Stevens-Johnson syndrome due to rifampicin.

Authors:  R Nyirenda; G V Gill
Journal:  Br Med J       Date:  1977-11-05

Review 7.  Hepatotoxicity of antitubercular treatments. Rationale for monitoring liver status.

Authors:  F Durand; G Jebrak; D Pessayre; M Fournier; J Bernuau
Journal:  Drug Saf       Date:  1996-12       Impact factor: 5.606

8.  Adverse effects of antituberculosis drugs.

Authors:  D J Girling
Journal:  Drugs       Date:  1982 Jan-Feb       Impact factor: 9.546

9.  Hepatotoxicity caused by the combined action of isoniazid and rifampicin.

Authors:  D S Askgaard; T Wilcke; M Døssing
Journal:  Thorax       Date:  1995-02       Impact factor: 9.139

10.  [Incidence of hepatotoxic side effects during antituberculous therapy (INH, RMP, EMB) in relation to the acetylator phenotype (author's transl)].

Authors:  E Musch; M Eichelbaum; J K Wang; W von Sassen; M Castro-Parra; H J Dengler
Journal:  Klin Wochenschr       Date:  1982-05-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.